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Abstract
Background: In the presented study we investigated the development of the humoral immune response against LSDV
during the process of re-vaccination of cattle over a time span of 5 months. In addition, the performance of different
serological techniques for antibody detection against LSDV was compared. For sample collection, an area without previous
LSD outbreak reports in Serbia was selected. Seventy-nine cattle from twenty farms vaccinated in 2016 and re-vaccinated in
2017 were included in the study. Two farms from the same area with good calving management were selected for
investigation of passive LSDV antibody transfer from vaccinated mothers to new-borne calves.
Results: All investigated cattle were healthy on the day of vaccination and during the whole study. Swelling at the injection
site or other side effects of vaccination did not occur after re-vaccination in the study.
Detection of LSD-specific antibodies was performed with the standard serological methods VNT and IFAT as well as a
commercially available Capripox double antigen multi-species-ELISA. Capripoxvirus-specific antibodies were detected 46 to
47weeks after vaccination in 2016, with VNT in 35.06% and with IFAT and ELISA in 33.77%. A secondary response was
observed in all three tests 1 month after re-vaccination with a significant increase in seropositive animals compared to the
results before re-vaccination. With all applied serological methods, the number of animals testing positive was significantly
higher at 1 and 5 months post re-vaccination than before re-vaccination. No significant statistical difference (p> 0.05) was
observed between the results of all three tests used. The sensitivity and specificity of ELISA was estimated to be SeELISA 91%
and SpELISA 87% calculated by the results of VNT and SeELISA 88% and SpELISA 76% calculated by the results of IFAT. Passive
antibody transfer from vaccinated mothers to new-born calves was investigated at 14 days after birth. Discrepancies for the
detection of LSDV specific antibodies between cows and newborn calves at the age of 14 days were observed in VNT and
IFAT, but not in ELISA.
Conclusion: Of all tests used the commercially available ELISA shows to be the most useful for high throughput analysis
compared to VNT or IFAT.
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Background
Lumpy skin disease (LSD) is a viral disease of cattle caused
by lumpy skin disease virus (LSDV) and is included in the
OIE list of notifiable animal diseases [1]. LSDV belongs to
the genus Capripoxvirus of the family Poxviridae together
with sheep pox (SPP) and goat pox (GTP) virus [2]. It is
widely accepted that transmission of LSDV mainly takes
place mechanically by blood-feeding arthropods such as
mosquitoes (Aedes aegypti), stable flies (Stomoxys calcitrans)
and ticks (Amblyomma hebraeum and Rhipicephalus appen-
diculatus) feeding on infected animals [3–6]. The disease
can manifest in different forms ranging from acute to
in-apparent, characterized by fever, lymphadenitis, skin nod-
ules, lesions of the ocular, nasal and oral mucous mem-
branes, and can in severe forms sometimes lead to death [7].
Development of nodules of different size starts after onset of
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fever, the number may range from a few nodules to the gen-
eralized form covering the entire body [8].
Over the past decades, LSD has spread from sub-Saharan
Africa, where it is considered endemic in many countries, to
the Middle East triggering concern of a further spread into
Europe and Asia. In 2013, the first LSD outbreak was re-
ported in Turkey where the disease subsequently became en-
demic. A further spread from Turkey into Greece was seen
in 2015, followed by outbreaks in Bulgaria, the Former Yugo-
slav Republic of Macedonia, Serbia, Albania and Kazakhstan
in 2016 [9]. On June 7, 2016 a first LSD outbreak was offi-
cially confirmed in Serbia, in the municipality of Bujanovac,
Ljiljance village, near the border to the Former Yugoslav Re-
public of Macedonia [10].
For successful LSD control, vaccination of all suscep-
tible animals is considered to be the main pillar, sup-
ported by other control measures such as stamping out,
animal movement restrictions and vector control. For
vaccination of cattle against LSD, live attenuated capri-
poxvirus vaccine strains were used, including the hom-
ologous LSDV Neethling strain and KSGP O-240
previously described as Kenyan sheep pox and goat pox
virus, or the heterologous RM65 SPP, Romanian SPP
and Gorgan GTP virus strains [11–14].
Facing the risk of a spread of LSD throughout the
country, disease control measures including mass vac-
cination were applied in Serbia. In 2016, all susceptible an-
imals were vaccinated using a LSDV Neethling vaccine
(Onderstepoort Biological Products, South Africa) after div-
iding the country into three zones. Vaccination in zone one
(infected zone) was done first starting from the outside and
working inwards. This was followed by vaccination in the
second (buffer zone) and third zone (Northern part of coun-
try). In 2017, re-vaccination of all susceptible animals was
performed with BOVIVAX LSD-N Neethling vaccine (M.C.I.
Sante Animale, Morocco) without zoning. Together with
vaccination total stamping out was implemented in
non-vaccinated herds when LSD was diagnosed, modified
stamping out of only the infected animals with clinical signs
and after laboratory confirmation of a field virus strain was
performed when LSD occurred in vaccinated farms [10].
During the LSD epidemic in Serbia in 2016, 225 outbreaks
with 267 affected animals were reported [15].
Annual re-vaccination and vaccination of calves de-
rived from vaccinated cattle at the age of 6 months is the
vaccination scheme recommended by the vaccine produ-
cer. Whilst vaccination will not induce immune response
in each vaccinated animal, mass vaccination will provide
good overall protection, if more than 80% of the popula-
tion are vaccinated [12]. A recent immunological study
following up LSD vaccination using Neethling, SPP and
GTP vaccine strains has shown that vaccination equally
stimulates humoral and cell-mediated immunity [16–18].
Although there are studies on the efficiency of vaccination
after a single vaccine application, to our knowledge there
are no published studies on the humoral response to the
LSDV Neethling vaccine in the field after vaccination and
re-vaccination.
Humoral immune response can be investigated by using
virus neutralization test (VNT), indirect fluorescent anti-
body test (IFAT) and ELISA [1, 19]. So far, VNT is the
only serological test validated by the OIE with a high spe-
cificity for detecting capripoxvirus-specific antibodies [1].
In serological investigations, IFAT should be used with
caution, considering the described cross-reactivity with
bovine papular stomatitis virus and other poxviruses [1].
A recently developed double antigen ELISA from ID vet®
with a high specificity and sensitivity for capripoxvirus
antibody detection according to the manufacturer, could
fill the gap of serological tools for mass screening.
The aim of this longitudinal study was to investigate
the humoral immune response of vaccinated cattle dur-
ing the re-vaccination campaign as well as of newborn
calves after colostrum intake. In addition, a comparison
of the results obtained by standard serological methods
(VNT and IFAT) with the results obtained by using a
commercially available ELISA in order to prove suitabil-
ity of ELISA was performed.
Results
Sampling and on-farm examination
Seventy-nine cattle from twenty farms vaccinated in 2016
and re-vaccinated in 2017 were included in the study. Of all
tested animals, two young heifers were not vaccinated in
2016, but all seventy-nine animals were vaccinated in 2017.
Vaccination of all cattle in 2016 and 2017 was done by the
same veterinary service. Except for one farm, where cattle
were kept on pasture and indoors, all animals were housed
indoors only with approximately 200–500m distance be-
tween farms without mixing of herds. On the vaccination
day and during the study all cattle were healthy with no clin-
ical signs of LSD or any other disease. Swelling at the injec-
tion site, which was described by the manufacturer (M.C.I.
Sante Animale, Morocco) as a side effect of vaccination in
vaccinated cattle, did not occur in this study. At the last time
point of sampling five animals were excluded from the inves-
tigation because the owners had sold them for slaughter with
no clinical signs of disease or other health problems. Passive
immunity investigation was performed with 17 re-vaccinated
cows and 20 calves (three cows gave birth to twins).
VNT
In VNT 27 cattle were tested positive after the first sam-
pling, the highest antibody titer was 1:512. A secondary
response was seen 1 month after re-vaccination with an
increase in the number of seropositive animals up to 60
together with an increase of antibody titers (Table 1).
Compared to the results before re-vaccination 5 animals
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had a higher antibody titer than 1 month after re-vaccin-
ation (320–256; 512–320; 256–200; 128–64 and 100–80).
The number of seropositive animals decreased from 60 to 42
five months after re-vaccination together with the antibody
titer. Higher antibody titers were observed in 7 animals 5
months after re-vaccination compared to the results from 1
month after re-vaccination (320–640; 256–512; 100–128;
50–800; 256–320; 80–128 and 25–40).
Ifat
Analyzing samples from before re-vaccination, 26 cattle
were seropositive with antibody titers from 40 to more
than 160. A secondary response was observed 1 month
after re-vaccination in 68 positive animals, with 37 tested
animals showing an antibody titer of 160. A drop in the
number of seropositive animals from 68 to 43 was seen
5 months post re-vaccination, with 19 animals showing
antibody titers of more than 160 (Table 2). Sensitivity
(Se) and specificity (Sp) were calculated with results
from VNT showing SeIFAT 85% and SpIFAT 86% with
0.90 positive predictive values (ppv) and 0.80 negative
predictive values (npv).
Elisa
At the first time point of sampling 26 cattle were positive
in the ELISA. Like in IFAT and VNT an increase in the
number of seropositive animals to up to 58 was observed
1 month after re-vaccination with an increase of S/P %
(percentage of positivity compared to the positive control).
Five months after re-vaccination the number of seroposi-
tive animals dropped to 43 together with a drop of S/P %
except in 7 animals (234–268; 116–306; 165–233; 178–
318; 258–270; 306–323 and 20–117) which had higher S/
P % compared to 1 month after re-vaccination (Fig. 1).
Higher sensitivity and specificity were observed with VNT
(91 and 87%, respectively, with 0.89 ppv and 0.88 npv)
compared to IFAT (SeELISA 88% and SpELISA 76%, with
0.82 ppv and 0.84 npv).
Comparative serological analysis
Detection of LSD-specific antibodies was possible at all three
time points of sampling and with all three tests used (Fig. 2).
A secondary response was observed 1 month after
re-vaccination with a significant increase in seropositive ani-
mals compared to the results before re-vaccination in all three
tests. Even though a secondary response was achieved, there
were still some cattle which did not seroconvert after
re-vaccination (VNT 19; IFAT 10 and ELISA 21) (Table 3). A
decrease in the number of seropositive animals from 1 month
to 5 months after re-vaccination was observed with all three
tests. With all applied serological methods, at 1 and 5 months
post re-vaccination the number of animals testing positive was
significantly higher than before re-vaccination (Table 4).
Maternally derived antibodies
The results of the investigation of maternally derived anti-
bodies are presented in detail in Table 5. Only 2 of the 17
cows reacted negative in less specific IFAT. For 9 of the 17
cows a positive VNT titer could be defined. Seven of these 9
VNT-positive cows reacted positive also in the ELISA. The
analyses of the pre-colostral collected serum sample showed
clear negative results in ELISA and IFAT. Passive antibody
transfer from vaccinated cows to newborn calves was ob-
served at 14 days after birth. All 9 VNT-positive calves reacted
also positive in the ELISA and all 11 VNT-negative calves
showed also a negative result in the ELISA. Discrepancies for
the detection of LSDV specific antibodies between cows and
newborn calves at the age of 14 days were observed in VNT
and IFAT (ID #11, #14 and #15), but not in ELISA.
PCR
EDTA blood, nasal and mouth swabs from all tested ani-
mal reacted negative in the PCR showing no presence of
LSDV field strain or Neethling vaccine strain genome.
All internal process, negative and positive controls
reacted as expected (data not presented).
Discussion
In the presented study we investigated the development of
the humoral immune response against LSDV during the
process of re-vaccination in cattle over a time span of 5
months, additionally comparing the performance of
Table 1 Number of animals listed by the titer of LSDV specific
antibody detected with VNT from three sampling time points
Number of animals by time of sampling
Antibody
titer
before re-
vaccination
1 month post re-
vaccination
5 months post re-
vaccination
over 300 3 6 6
200–300 3 10 2
100–200 8 14 9
50–100 5 13 7
10–50 8 17 18
under 10
(negative)
52 19 32
Table 2 Number of animals listed by the titer of LSDV specific
antibody detected with IFAT from three sampling time points
Number of animals by time of sampling
Antibody titer before
re-vaccination
1 month post
re-vaccination
5 months post
re-vaccination
over 160 10 37 19
80 3 22 13
40 13 9 11
border line 7 8 9
under 40 (negative) 46 3 22
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different serological techniques. Samples for the study were
collected in an area in Serbia without reports of previous
LSD outbreaks. Furthermore, all clinical investigations during
the different sample collections as well as negative testing of
all collected samples by capripoxvirus-qPCR confirmed free-
dom of LSDV field strain in the analyzed farms.
Besides the important cell-mediated immune response, the
easier to detect humoral immune response can provide sig-
nificant information about the success of vaccination, but is
time limited. Even though no new LSD outbreak was re-
ported in Serbia after implementation of a blanket vaccin-
ation in the cattle population in 2016, the status of immunity
against LSDV was poorly understood. The current know-
ledge on the time span of antibody detection after vaccin-
ation is fairly heterogeneous. A significant increase of
capripoxvirus-specific antibody titers is described to be seen
from day 21 up to day 42 after vaccination, and antibodies
remain detectable for about 7months [1]. A recent
immunological study conducted in cattle after vaccination
with LSDV showed that detection of specific antibodies is
limited to 40weeks post vaccination [16]. In the presented
study, detection of LSD-specific antibodies in cattle vacci-
nated in 2016 was possible 46 to 47weeks after vaccination
(35.06% by VNT and in 33.77% by IFAT and ELISA). These
results suggest that LSD-specific antibodies might be de-
tected longer than described so far. In our study, a second-
ary response was observed after re-vaccination showing a
significant increase in seropositive animals in all three tests
used. The detection of rising antibody titers in some ani-
mals 1 month after re-vaccination is concurrent with previ-
ously described findings [16]. Higher level of detected
antibodies can be attributed to better immune response to
vaccination. In the study of Kitching [20] it was demon-
strated that serum from sheep immune to capripoxvirus in-
fection protected recipient sheep against challenge with
virulent capripoxvirus confirming that antibody are
Fig. 1 Immune response detected with ELISA from three sampling time points. a – non-responders after first sampling; b – responders after first
sampling; red line – cut off value ≥30
Fig. 2 Graphic view of detected positive and negative cattle with three tests from three sampling times showing secondary response
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sufficient in protection against capripoxvirus infection.
Nevertheless, a robust number of cattle remained serologic-
ally negative after re-vaccination. Missing seroconversion in
a certain number of animals vaccinated against LSD was
already described by poor immunogenicity due to over-at-
tenuation of Neethling and KSGP vaccine [14]. In the same
study of Gari et al. [14] animals which were vaccinated with
Gorgon vaccine, only 50% developed immune response after
vaccination, but all animals were protected against capripox-
virus challenge. All three tests target the same biological fac-
tor and no significant statistical difference was seen between
them. A mismatch of detected positive and negative cattle
was seen to occur between ELISA and VNT in 26 cases,
between ELISA and IFAT in 40 cases and between VNTand
IFAT in 34 cases. In the study of Babiuk et al. [21], the same
nonconformity of serological tests was reported, which was
explained by detection of different anti-capripoxvirus anti-
bodies with the different tests used.
Use of standard serological tests (VNT and IFAT) for
investigation of the humoral immune response has its
disadvantages, as they are time consuming, require
handling of live virus, and high-throughput analyses are
not possible. VNT as the only validated test was used as
gold standard for confirmation of the results obtained
with two other tests. The main disadvantage of using
VNT is that it requires live LSDV which is restricted to
Table 3 Detection of positive and negative cattle by sampling time point showing secondary response after re-vaccination
before/1 m. p. re-vaccination before/5 m. p. re-vaccination 1 / 5 m. p. re-vaccination
VNT positive/stay positive 27 23 42
positive/turned negative 0 2 15
negative/turned positive 33 19 0
negative/stay negative 19 30 17
IFAT positive/stay positive 25 20 42
positive/turned negative 1 4 22
negative/turned positive 43 23 1
negative/stay negative 10 27 9
ELISA positive/stay positive 26 22 42
positive/turned negative 0 1 13
negative/turned positive 32 21 1
negative/stay negative 21 30 18
Table 4 Statistical significance calculated between tests and between sampling time points
Time of sampling Test P value Result
before re-vaccination VNT/IFAT 1 p > 0.05
VNT/ELISA 1 p > 0.05
IFAT/ELISA 1 p > 0.05
1 month post re-vaccination VNT/IFAT 0.1549 p > 0.05
VNT/ELISA 0.855 p > 0.05
IFAT/ELISA 0.0738 p > 0.05
5 months post re-vaccination VNT/IFAT 1 p > 0.05
VNT/ELISA 1 p > 0.05
IFAT/ELISA 1 p > 0.05
before / 1 month post re-vaccination VNT/VNT <0.0001 p<0.0001
before / 5 months post re-vaccination VNT/VNT 0.0059 p<0.01
1 month / 5 months post re-vaccination VNT/VNT 0.0161 p<0.05
before / 1 month post re-vaccination IFAT/IFAT <0.0001 p<0.0001
before / 5 months post re-vaccination IFAT/IFAT 0.0021 p<0.01
1 month / 5 months post re-vaccination IFAT/IFAT 0.0001 p<0.001
before / 1 month post re-vaccination ELISA/ELISA <0.0001 p<0.0001
before / 5 months post re-vaccination ELISA/ELISA 0.0021 p<0.01
1 month / 5 months post re-vaccination ELISA/ELISA 0.0601 p > 0.05
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be used in national reference laboratories operating in
high-level bio-containment facilities [22].
Analysis of the results of three serological tests used in
this study shows that IFAT gave the highest number of
seropositive animals 1 month after re-vaccination followed
by VNT and ELISA. The high sensitivity of IFAT could be
attributed to cross-reactivity of IFAT with bovine papular
stomatitis virus or with pseudo-cowpox virus observed at
a lower dilution (≤1/8), [1, 23]. It must be noted though
that there was no documented clinical infection with bo-
vine papular stomatitis virus or pseudo-cowpox virus in
animals included in this study and that by starting dilution
at 1:40 we aimed to avoid a false positive reaction. In the
study of Gari et al. [19] Se and Sp of IFAT were higher, 92
and 88%, respectively, compared to our study, where SeI-
FAT was 85% and SpIFAT 86%.
The newly developed ELISA capripoxvirus double anti-
gen multi-species, with a claimed specificity of > 99.7% by
the manufacturer shows suitability for serological investiga-
tion of a vaccinated cattle population in the field with
nearly the same results as VNT. Calculating sensitivity and
specificity of ELISA was estimated to be SeELISA 91% and
SpELISA 87% to VNT and SeELISA 88% and SpELISA 76% to
IFAT. The ELISA test has many advantages compared to
standard serological tests making it ideal for time- and
cost-efficient analysis of a large number of samples in mass
screening activities.
The component of our study looking into the passive
transfer of antibodies confirmed that seropositive cows
provide colostral antibodies to their calves. For detection
of passive antibody transfer IFAT again shows the high-
est number of positive animals compared to VNT and
ELISA. In general, suitability of the ELISA for investiga-
tion of passive antibody transfer was shown by the fact
that failure of detection of LSDV-specific antibodies in
calves at the age of 14 days did not occur. Nevertheless,
the missing of LSDV-specific antibodies in new-borne
calves at the age of 14 days despite the detection of anti-
bodies in the according mothers by VNT and IFAT (ID
#11, #14 and #15) could be explained by the fact that not
all cows will provide the same colostrum quality [24]. On
the other hand, one calf (#17) was detected positive at the age
of 14 days only with IFAT although the mother was negative.
This finding can be attributed to a higher concentration of
antibodies in colostrum than in the serum of cow [25] and to
the fact that with different tests different anti-capripoxvirus
antibodies could be detected [21]. For successful transfer of
antibodies via colostrum four factors must be respected: feed-
ing colostrum with high immunoglobulin concentration (> 50
mg/mL of IgG), feeding an adequate volume of colostrum,
feeding colostrum promptly after birth, and avoiding bacterial
contamination of colostrum [26–28]. In this study, all calves
were in good condition at birth and took colostrum in suffi-
cient amounts between the first 30min to 2 h after birth, with
no clinical signs of disease during the first 14 days of life.
According to the vaccine producer, vaccination of calves
derived from vaccinated mothers should be done at the age
of 6 months because of maternally derived antibodies. From
recent studies of Agianniotaki et al. [29] maternally derived
antibodies can be detected 3 days after feeding with colos-
trum until 3 months of age, leaving a potential vaccination
gap of 3 months in some calves.
Conclusion
Based on the results of this study, it can be concluded
that re-vaccination leads to a secondary response in the
cattle population and significantly increases the number
of animals with detectable antibody titers. The detection
of capripoxvirus-specific antibodies nearly eleven months
post vaccination (46 to 47weeks) in a certain number of ani-
mals with all three tests shows that in individual cattle
humoral immune response can last longer than 7 months.
The commercially available capripoxvirus ELISA delivered
very good results compared to VNT or IFAT. The ELISA
will be the most useful serological technique for high
throughput analyses.
Table 5 Detailed results of passive LSDV specific antibody
transfer from vaccinated cows to new-borne calves
Cow Calf
ID Serum ID 0 day old 14 days old
ELISA VNT IFAT ELISA IFAT ELISA VNT IFAT
1 −2 <1:10 1:80 1 −2 <1:40 -1 <1:10 1:80
2 -1 <1:10 1:40 2 −2 <1:40 0 <1:10 1:160
3 −2 <1:10 1:80 3 −2 <1:40 0 <1:10 1:40
4 -2 <1:10 1:160 4 -2 <1:40 −1 <1:10 1:160
5 49 1:32 1:160 5 −1 <1:40 101 1:32 1:80
6 383 1:256 1:160 6 −1 <1:40 305 1:200 1:160
7 140 1:100 1:160 7 −2 <1:40 227 1:64 1:80
8 −2 <1:10 1:160 8 −2 <1:40 −1 <1:10 1:40
9 −3 <1:10 <1:40 9 −2 <1:40 −2 <1:10 <1:40
10 241 1:128 1:160 10 −2 <1:40 315 1:200 1:160
11 −3 1:16 1:80 11 −1 <1:40 −3 <1:10 1:40
12 281 1:128 1:160 12 −1 <1:40 269 1:80 1:160
13 68 1:20 1:80 13 −2 <1:40 71 1:40 1:80
13 −1 <1:40 65 1:20 1:40
14 1 <1:10 1:160 14 −2 <1:40 −2 n.d. <1:40
14 −2 <1:40 −1 <1:10 <1:40
15 3 1:25 1:160 15 −2 <1:40 1 n.d. <1:40
16 190 1:128 1:80 16 −2 <1:40 192 1:64 1:80
16 −3 <1:40 254 1:80 1:80
17 −3 <1:10 <1:40 17 −3 <1:40 −3 <1:10 1:80
Cut off values: ELISA ≥30; VNT ≥1:10 and IFAT ≥1:40. n.d. not determined
Milovanović et al. BMC Veterinary Research           (2019) 15:80 Page 6 of 9
Methods
Sample collection
Seventy-nine animals from 20 randomly selected farms in
Vrdila village in Kraljevo municipality with no previously
detected LSD outbreaks in this area were included in the
longitudinal serological investigation. Sample collection
was performed three times in 2017. The first sample col-
lection was performed before re-vaccination in 2017, the
second 1 month after re-vaccination in 2017 and the third
5 months after re-vaccination in 2017. Nasal and oral
swabs were collected at all three time points of sampling
for detection of a potential circulation of Neethling vac-
cine strain and field strain of LSDV.
During sample collections, a clinical evaluation of all an-
imals was performed looking for unspecific clinical signs
of disease such as fever, mastitis, nasal, oral or ocular dis-
charge and presence of visible or palpable nodules. For
the investigation of passive immunity transfer in
new-born calves, 17 cattle from two farms with good calv-
ing management and strong biosecurity measures were se-
lected. All calves were separated from their mothers after
birth. The newborns were fed with 2 l of colostrum be-
tween 30min and 2 h after birth. Plain vacutainer tubes
without anticoagulant BD Vacutainertm 4,055,269 (Belliver
Industrial Estate, UK) and with EDTA anticoagulant Vacu-
ette® tube A170434K (Greiner Bio-One, Austria) were
used for blood collection from all cattle via coccygeal
venipuncture and from calves via Jugular venipuncture.
Blood from cows was collected on the day of calving and
from calves before taking colostrum and at the age of 14
days. After sample collection all animals were further used
in agriculture production.
Sample processing
Blood samples without anticoagulant were allowed to clot
for 3 h at room temperature and then serum was extracted
by centrifuging at 2000 RPM for 20min and aliquot in 1.5
ml centrifugal tubes. Swab material was collected using syn-
thetic swabs (Copan, Italy) and immediately immersed into
the Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco,
USA) supplemented with 1% of antibiotics (Penicillin 1000
IU - Streptomycin 10mg; Sigma, Germany) and 1% of anti-
mycotic (Amphotericin B; Sigma, Germany). All samples
were stored at − 20 °C until examination.
Serological methods
Detection of LSDV specific antibodies from investigated ani-
mals was assessed by using virus neutralization test (VNT),
indirect fluorescent antibody test (IFAT), and ELISA (ID vet®
Capripox Double Antigen Multi-species, Montpellier,
France). VNT is the only OIE-validated test for detection of
LSDV specific antibody. For VNT and IFAT, MDBK cells
were grown using DMEM supplemented with 10% foetal calf
serum (FCS) and incubated at 37 °C with 5% CO2.
VNT
All tested serum samples including positive and negative
control serum were incubated at 56 °C for 30min. To as-
sess the titer of LSDV specific antibody, triplicates of
tested serial 2-fold dilution series were titrated against a
constant titer of Neethling vaccine strain 100TCID50 (The
Pirbright Institute, Pirbright, UK). The tested serum, posi-
tive and negative control serum were diluted in DMEM
without FCS (from 1:10 to 1:1280). Serum dilutions and
the fixed amount of virus strain were incubated for 2 h at
37 °C. After the neutralization step 100 μL suspension of
MDBK cells in DMEM with 10% FCS was added to each
well. In each test one control plate was included with only
virus titration and titration of positive and negative con-
trol serum. Plates were incubated at 37 °C, 5% CO2. After
4 days plates were examined for appearance of cytopatho-
genic effect (CPE) and final reading was taken on day 7.
Results were recorded and titer was calculated using the
Spearman and Kaerber method [30]. Samples with an
antibody titer of ≥1:10 were considered as positive.
Ifat
MDBK cells were incubated for 1 day in 96 well cell culture
plates to obtain an 80–90% confluent monolayer. Cells were
infected with 100 μL of 100TCID50 virus suspension of
Neethling vaccine virus strain (The Pirbright Institute, Pirb-
right, UK). Rows one, five, and nine were not infected for
surveillance of non-specific interaction of tested sera and
cells. After 48 h of incubation at 37 °C and 5% CO2 infected
and non-infected MDBK cells were fixated with 200 μL
Acetone-Methanol 1:1 for 20min. After fixation, MDBK
cells were blocked adding 100 μL Saponin-Blocking-Buffer
(0.2% w/v BSA, 0.1% w/v NaN3, and 0.05% Saponin) for 30
min to reduce non-specific reaction. Tested serum, positive
and negative control serum were prepared in log dilutions
1:40, 1:80 and 1:160 in Saponin-Blocking-Buffer. Anti-bovine
gamma globulin conjugated with fluorescein isothiocyanate
obtained from rabbit was prepared at a dilution of 1:400 in
Saponin-Blocking-Buffer and 100 μL were added to each
well. Reading of plates was done using Carl Zeiss Florescence
microscope under 40X magnification. The test was consid-
ered valid if positive sera gave clear green fluorescence at
each dilution step and negative serum was without flores-
cence signal. Tested sera were considered positive if at a
lower dilution clear green fluorescence signal was present
and negative when no fluorescence signal was seen.
Elisa
Antibody detection via ELISA was performed using ID
Screen® Capripox double antigen Multi-species ELISA kit
from ID vet® (Montpellier, France) according the manufac-
turer’s instructions.
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Polymerase chain reaction
DNA from swab samples and EDTA blood together with in-
ternal control RNA (IC-RNA) added to each sample [31]
was extracted using the NucleoMag Vet Kit (Macherey-Na-
gel GmbH, Germany) with King Fisher Flex (ThermoFisher
Scientific, Finland) machine. Detection of viral genome from
material was done by pan real-time PCR reaction based on
P32 capripoxvirus gene amplification using the previously
published protocol of Bowden et al. [32] modified according
to Dietze et al. [33] and with included IC system [31].
Statistics
Statistical analysis was performed by Fisher exact test with
program GraphPad Prisma version 7 (San Diego, CA,
USA). Statistical significance was calculated between tests
from each sampling time point and between the same test
from different sampling time points. Calculation of sensitiv-
ity and specificity of the tests was performed with cattle
from all three sampling time points.
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